MedTrace Logo

Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence

NCT06251063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this study is to test a web-based psychoeducational resource for adolescents with central disorders of hypersomnolence and their families. The investigators hope to assess the website's usability, acceptability, and feasibility, as well as its potential effect on social relationship health.

Participants will be asked to review the content of the psychoeducational websites. The participants will then provide feedback on the website, as well as the adolescent's social relationships and social health before and after reviewing the website through online surveys.

Conditions

Interventions

BEHAVIORAL

Web-based psychoeducational resource

The website will incorporate animations/illustrations to enhance comprehension, patient stories, and video-based expert explanations. The materials will address the following content areas: * Provide families with data demonstrating how prevalent social relationship struggles are for children with CDH. * Describe specific social challenges that commonly affect children with CDH. * Explain the impact that medications typically prescribed for CDH may have on social relationship health. * Help families advocate for their child's social needs at school. * Support children and their families in decision-making about appropriate disclosure with peers at school and in extracurricular settings. * Offer strategies to support families in raising the issue of social relationship health with the child's sleep physician. * Provide a list of programming which offers children both structured and unstructured opportunities for social engagement

Sponsors & Collaborators

Principal Investigators

  • Eric Zhou, PhD · Boston Children's Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2025-05-10
Completion
2025-05-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06251063 on ClinicalTrials.gov